- Home
- ORIC vs MEGI Comparison
ORIC vs MEGI Comparison
Compare ORIC & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- MEGI
- Stock Information
- Founded
- ORIC 2014
- MEGI 2021
- Country
- ORIC United States
- MEGI United States
- Employees
- ORIC N/A
- MEGI N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- MEGI Investment Managers
- Sector
- ORIC Health Care
- MEGI Finance
- Exchange
- ORIC Nasdaq
- MEGI Nasdaq
- Market Cap
- ORIC 735.3M
- MEGI 647.0M
- IPO Year
- ORIC 2020
- MEGI N/A
- Fundamental
- Price
- ORIC $7.68
- MEGI $12.65
- Analyst Decision
- ORIC Strong Buy
- MEGI
- Analyst Count
- ORIC 10
- MEGI 0
- Target Price
- ORIC $19.13
- MEGI N/A
- AVG Volume (30 Days)
- ORIC 1.6M
- MEGI 178.0K
- Earning Date
- ORIC 02-18-2025
- MEGI 01-01-0001
- Dividend Yield
- ORIC N/A
- MEGI 11.40%
- EPS Growth
- ORIC N/A
- MEGI N/A
- EPS
- ORIC N/A
- MEGI N/A
- Revenue
- ORIC N/A
- MEGI N/A
- Revenue This Year
- ORIC N/A
- MEGI N/A
- Revenue Next Year
- ORIC N/A
- MEGI N/A
- P/E Ratio
- ORIC N/A
- MEGI N/A
- Revenue Growth
- ORIC N/A
- MEGI N/A
- 52 Week Low
- ORIC $6.33
- MEGI $10.63
- 52 Week High
- ORIC $16.65
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- ORIC 36.65
- MEGI 54.45
- Support Level
- ORIC $7.34
- MEGI $12.50
- Resistance Level
- ORIC $14.67
- MEGI $12.67
- Average True Range (ATR)
- ORIC 1.56
- MEGI 0.16
- MACD
- ORIC -0.45
- MEGI 0.03
- Stochastic Oscillator
- ORIC 4.64
- MEGI 91.75
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.